Emboline has raised $55M in a series D round. The company has developed an embolic protection device designed to provide total embolic protection by capturing and removing all debris from transcatheter procedures.
AliveCor said in its claim that it wants to block the importation of all the Apple Watches in U.S. – and said the tech giant is infringing on three counts of ECG patents.
Data from the investigator-initiated Early neo2 Registry and ITAL-neo Registry studies show low rates of paravalvular leakage and permanent pacemaker implementation.
Julie Brewer, president of Medtronic's cardiovascular diagnostics and services business, talks about the company's decision to use wafer-scale manufacturing instead of traditional methods for the device that won best-in-show in this year's MDEAs.